What is being built?

Animal health company creates 120 new jobs in Hungary

Published

Photo: Facebook / CevaPhylaxiaCampus
Ceva-Phylaxia Zrt. strengthens its presence in Monor with a new vaccine factory. The ground-breaking ceremony has taken place and the new plant is expected to be operational by the end of 2026.

Ceva will set up a state-of-the-art plant in Monor, where it will produce fermentation-based, multicomponent inactivated vaccines for animals to prevent infectious diseases.

"The Ceva Group has made a long-term commitment to Hungary and attaches great importance to the high value and high performance of the work carried out in Ceva-Phylaxia. Nothing is more proof of this than today's announcement of the construction of the new plant. It is primarily thanks to the outstanding expertise and dedication of my colleagues that our company is becoming an increasingly dominant player in the domestic and international animal health sector."

- the statement quoted Tamás Szamkó, CEO of Ceva-Phylaxia, as saying.

Ceva Santé Animale (Ceva), the fifth largest animal health company in the world. Led by experienced veterinarians and specialists, they offer innovative healthcare solutions to ensure the highest level of care and welfare for all animals. Through Phylaxia, the Group's Hungarian subsidiary, Ceva, a veterinary pharmaceutical company with a century-long history in our country, is a leading player and employer in the industry.

With nearly 1300 employees in Budapest and Monor, the company is currently Hungary's largest veterinary company in the fields of research development, vaccine production and trade.

Source : Link

Popular